#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Human papilloma virus immunisation Polycystic liver disease Pancreatic neuroendocrine tumour Mucous membrane pemphigoid Hereditary motor and sensory neuropathy Diffuse large B-cell lymphoma Neurofibromatosis Glycogen storage disease type I Adenoid cystic carcinoma Hypereosinophilic syndrome Marginal zone lymphoma refractory Hepato-lenticular degeneration Immune-mediated enterocolitis Hereditary angioedema Lymphangiosarcoma More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma – Life with Disease SAPHO syndrome Mantle cell lymphoma stage IV – Treatment Andersen-Tawil syndrome – Trials in Disease Pleural mesothelioma malignant – Diagnostics Haemophilia B without inhibitors – Trials in Disease Idiopathic pulmonary fibrosis – Life with Disease Mucopolysaccharidosis II – Trials in Disease Pelizaeus-Merzbacher disease Marginal zone lymphoma refractory More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tadekinig Alfa Timrepigene Emparvovec CHONDROITIN SULFATE SODIUM Odm-111 Nortriptyline Hydrochloride Encorafenib DCC-3084 Clofutriben Enzalutamide Golcadomide Idelalisib JX10 GSK3862995B Sodium Nitroprusside Dihydrate Colestyramine Hydroxocobalamin Crd-4730 Fasudil Hydrochloride Interferon Gamma Amlodipine More therapies…

    Learn about Your Condition

    Allergic respiratory disease Breast neoplasm Thrombosis Hyperplasia adrenal Myeloproliferative neoplasm Upper limb fracture Macular telangiectasia Oesophageal carcinoma Hip arthroplasty Pre-eclampsia Deep vein thrombosis Polycystic ovarian syndrome Thyroid disorder Laryngeal cancer stage II Huntington's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lung neoplasm malignant

  • Study on the Safety of Lanreotide and Metformin for Patients with Advanced Gastrointestinal or Lung Carcinoids

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Lung neoplasm malignant
    Investigated Drugs:
    • Metformin Hydrochloride
    • Lanreotide
    Italy

  • Study on Patritumab Deruxtecan and Zirconium (89Zr) Patritumab Deruxtecan for Patients with Advanced EGFR Mutation Positive Lung Cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zirconium (89Zr) Patritumab Deruxtecan
    • Patritumab Deruxtecan
    The Netherlands

  • Feasibility Study of Fluorescence Bronchoscopy Using bevacizumab-800CW in Patients with Suspected Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Bevacizumab
    The Netherlands

  • Study of osimertinib and febuxostat to improve drug delivery in patients with EGFR-mutated non-small cell lung cancer without brain metastases

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Febuxostat
    • Osimertinib
    The Netherlands

  • Testing F-18-AraG imaging scan reliability in patients with lung cancer using repeat scans

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Nelarabine
    The Netherlands

  • Evaluation of Lung Function Using Xenon Gas with CT Imaging in Lung and Breast Cancer Patients Receiving Radiotherapy

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Breast cancer
    Investigated Drugs:
    • XENON (133XE)
    Belgium
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!